The Enterprise Value as of December 2025 (TTM) for Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) is 2.87B

According to Gwo Xi Stem Cell Applied Technology Co. , Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 2.87B. This represents a change of -7.76% compared to the average of 3.11B of the last 4 quarters.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Historical Enterprise Value (quarterly & annually)

How has 6704.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Gwo Xi Stem Cell Applied Technology Co. , Ltd over the last ten years is 3.79B. The current 2.87B Enterprise Value has changed 7.47% with respect to the historical average. Over the past ten years (40 quarters), 6704.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 4.56B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gwo Xi Stem Cell Applied Technology Co. , Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Average Enterprise Value

How has 6704.TWO Enterprise Value performed in the past?

The current Enterprise Value of Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Enterprise Value vs. Peers

How is 6704.TWO’s Enterprise Value compared to its peers?

Gwo Xi Stem Cell Applied Technology Co. , Ltd’s Enterprise Value is greater than TaiRx, Inc. (2.42B), greater than Steminent Biotherapeutics Inc. (2.77B), greater than Anti-Microbial Savior BioteQ Co., Ltd (2.48B), greater than HeXun Biosciences Co., Ltd. (2.40B), greater than GlycoNex Incorporation (2.21B), greater than Taiwan Bio Therapeutics Co., Ltd (2.09B), less than Intech Biopharm Corporation (3.68B), greater than Hcmed (2.28B), greater than Sinew Pharma Inc. (2.76B), greater than Advagene Biopharma Co., Ltd. (1.73B),

Build a custom stock screener for Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gwo Xi Stem Cell Applied Technology Co. , Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gwo Xi Stem Cell Applied Technology Co. , Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.